Skip to main content
. 2015 May 6;23(8):1042–1050. doi: 10.1038/ejhg.2015.81

Table 1b. Clinical characteristics of entire cohort by OI type and subdivided by age.

  OI type I OI type III OI type IV
Individuals (n) 151 29 42
Gender (children, F/M) 32/39 11/4 7/9
Gender (adult, F/M) 33/46 10/4 8/18
Age baseline (children, average) 4.49±3.28 0.69±0.82 1.13±1.06
Age baseline (adult, average) 18.77±14.64 17.63±19.37 13.63±10.25
BMD baseline (SD/Z-scores, children) −2.39±1.50 −5.02±1.35 −4.18±1.40
BMD baseline (SD/Z-scores, adult)) −2.96±1.35 −5.08±2.61 −4.33±1.81
P-value NS NS NS
Age database lock (average) 22.37±16.86 22.55±18.73 19.64±12.04
Age database lock (children) 9.22±4.71 9.27±4.82 9.25±5.64
Age database lock (adults) 34.18±14.98 36.79±17.58 26.04±10.35
Height database lock (SD/Z-scores, children) −0.95±1.39 −4.97±1.58 −1.77±1.25
Height database lock (SD/Z-scores, adult) −1.18±1.38 −9.38±2.79 −3.04±3.06
P-value NS <0.0001 NS
Fractures database lock (per year, children) 0.69±0.85 4.94±12.50 1.91±2.02
Fractures database lock (Per year, adult) 0.48±0.47 2.44±1.66 1.00±0.71
P-value 0.0983 NS 0.0691
Vertebral fractures database lock (yes, children) 65% 100% 82%
Vertebral fractures database lock (yes, adult) 78% 90% 95%
P-value NS NS NS

Abbreviation: NS, not significant. Clinical characteristics of all 222 individuals with OI types I, III, and IV, irrespective of collagen I mutation status. Baseline BMD values are presented to avoid including bisphosphonate effects, while remaining characteristics are registered at database lock (31 December 2013), average age by OI type stated for both time points. Figures stated are averages or frequencies for each group, as appropriate. Children defined as 18 years or younger at database lock (31 December 2013).